Top Healthcare Stocks by Net Income
Top healthcare companies ranked by net income, latest annual filings.
What Net Income Means for Healthcare Companies
Net income in healthcare pulls together wildly different economic profiles under a single line: integrated providers running thin margins on patient volume, device makers earning durable returns on installed bases, and drug developers booking large research charges against uncertain future payoffs. That mix means a headline profit figure can reflect a stable dividend-paying business or a capital-consuming pipeline bet, and the number alone rarely tells you which.
Why It Matters in Healthcare
Firms with approved therapies and favorable payer mix can generate durable earnings protected by regulatory moats, making sustained net income a meaningful quality signal once a product clears trials and reimbursement. Earlier-stage developers, by contrast, often carry years of negative profit while research costs run ahead of revenue. One-time milestone payments and divestitures can also swing a single year of reported profit without changing the underlying commercial trajectory.
What to Read Alongside
Read net income alongside Free Cash Flow to confirm reported profit converts into real cash, Gross Margin for the pricing power behind approved products and protected patents, and Return on Equity for capital efficiency across distinct subindustry models.
| # | Symbol | Company | Sector | ||
|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | Healthcare | $26.80B | $599.12B |
| 2 | LLY | Eli Lilly and Company | Healthcare | $20.64B | $1039.78B |
| 3 | MRK | Merck & Co., Inc. | Healthcare | $18.25B | $350.29B |
| 4 | NVS | Novartis AG | Healthcare | $13.97B | $270.68B |
| 5 | UNH | UnitedHealth Group Incorporated | Healthcare | $12.06B | $339.08B |
| 6 | AZN | AstraZeneca PLC | Healthcare | $10.23B | $241.66B |
| 7 | GILD | Gilead Sciences, Inc. | Healthcare | $8.51B | $183.41B |
| 8 | PFE | Pfizer Inc. | Healthcare | $7.77B | $161.70B |
| 9 | AMGN | Amgen Inc. | Healthcare | $7.71B | $223.19B |
| 10 | BMY | Bristol-Myers Squibb Company | Healthcare | $7.05B | $115.76B |
| 11 | HCA | HCA Healthcare, Inc. | Healthcare | $6.78B | $99.75B |
| 12 | TMO | Thermo Fisher Scientific Inc. | Healthcare | $6.72B | $245.16B |
| 13 | ABT | Abbott Laboratories | Healthcare | $6.52B | $177.55B |
| 14 | CI | The Cigna Group | Healthcare | $5.96B | $74.66B |
| 15 | ELV | Elevance Health, Inc. | Healthcare | $5.66B | $92.23B |
| 16 | MCK | McKesson Corporation | Healthcare | $4.76B | $112.15B |
| 17 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | $4.50B | $77.54B |
| 18 | ABBV | AbbVie Inc. | Healthcare | $4.23B | $484.83B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | $3.95B | $122.98B |
| 20 | DHR | Danaher Corporation | Healthcare | $3.61B | $156.65B |
| 21 | SYK | Stryker Corporation | Healthcare | $3.25B | $108.38B |
| 22 | BSX | Boston Scientific Corporation | Healthcare | $2.89B | $62.77B |
| 23 | ISRG | Intuitive Surgical, Inc. | Healthcare | $2.86B | $149.10B |
| 24 | ZTS | Zoetis Inc. | Healthcare | $2.67B | $30.70B |
| 25 | THC | Tenet Healthcare Corporation | Healthcare | $2.37B | $21.49B |
| 26 | GEHC | GE HealthCare Technologies Inc. | Healthcare | $2.08B | $31.07B |
| 27 | CVS | CVS Health Corporation | Healthcare | $1.77B | $111.97B |
| 28 | CAH | Cardinal Health, Inc. | Healthcare | $1.71B | $55.51B |
| 29 | BDX | Becton, Dickinson and Company | Healthcare | $1.68B | $51.04B |
| 30 | SOLV | Solventum Corporation | Healthcare | $1.56B | $14.69B |
| 31 | COR | Cencora, Inc. | Healthcare | $1.55B | $62.99B |
| 32 | RMD | ResMed Inc. | Healthcare | $1.52B | $33.06B |
| 33 | UHS | Universal Health Services, Inc. | Healthcare | $1.49B | $10.55B |
| 34 | TEVA | Teva Pharmaceutical Industries Limited | Healthcare | $1.41B | $48.11B |
| 35 | IQV | IQVIA Holdings Inc. | Healthcare | $1.36B | $42.91B |
| 36 | UTHR | United Therapeutics Corporation | Healthcare | $1.33B | $23.31B |
| 37 | A | Agilent Technologies, Inc. | Healthcare | $1.30B | $48.38B |
| 38 | BIIB | Biogen Inc. | Healthcare | $1.29B | $33.82B |
| 39 | ARGX | argenx SE | Healthcare | $1.29B | $50.47B |
| 40 | INCY | Incyte Corporation | Healthcare | $1.29B | $22.02B |
| 41 | HUM | Humana Inc. | Healthcare | $1.19B | $50.48B |
| 42 | DVA | DaVita Inc. | Healthcare | $1.08B | $11.62B |
| 43 | EW | Edwards Lifesciences Corporation | Healthcare | $1.07B | $49.15B |
| 44 | IDXX | IDEXX Laboratories, Inc. | Healthcare | $1.06B | $40.99B |
| 45 | DGX | Quest Diagnostics Incorporated | Healthcare | $0.99B | $25.68B |
| 46 | GMAB | Genmab A/S | Healthcare | $0.96B | $22.49B |
| 47 | VEEV | Veeva Systems Inc. | Healthcare | $0.91B | $48.84B |
| 48 | LH | Labcorp Holdings Inc. | Healthcare | $0.88B | $25.44B |
| 49 | MTD | Mettler-Toledo International Inc. | Healthcare | $0.87B | $32.02B |
| 50 | ILMN | Illumina, Inc. | Healthcare | $0.85B | $40.95B |
| 51 | DXCM | DexCom, Inc. | Healthcare | $0.84B | $32.10B |
| 52 | EXEL | Exelixis, Inc. | Healthcare | $0.78B | $14.75B |
| 53 | STE | STERIS plc | Healthcare | $0.78B | $21.23B |
| 54 | RPRX | Royalty Pharma plc | Healthcare | $0.77B | $25.19B |
| 55 | BIO | Bio-Rad Laboratories, Inc. | Healthcare | $0.76B | $9.73B |
| 56 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | $0.71B | $17.56B |
| 57 | PTCT | PTC Therapeutics, Inc. | Healthcare | $0.68B | $5.00B |
| 58 | WAT | Waters Corporation | Healthcare | $0.64B | $42.17B |
| 59 | SNN | Smith & Nephew plc | Healthcare | $0.63B | $11.66B |
| 60 | EHC | Encompass Health Corporation | Healthcare | $0.57B | $12.27B |
| 61 | HOLX | Hologic, Inc. | Healthcare | $0.57B | $16.97B |
| 62 | GMED | Globus Medical, Inc. | Healthcare | $0.54B | $10.25B |
| 63 | WST | West Pharmaceutical Services, Inc. | Healthcare | $0.49B | $26.17B |
| 64 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | $0.48B | $13.74B |
| 65 | MOH | Molina Healthcare, Inc. | Healthcare | $0.47B | $10.94B |
| 66 | HCM | HUTCHMED (China) Limited | Healthcare | $0.46B | $2.35B |
| 67 | RDY | Dr. Reddy's Laboratories Limited | Healthcare | $0.45B | $10.64B |
| 68 | MEDP | Medpace Holdings, Inc. | Healthcare | $0.45B | $17.02B |
| 69 | TGTX | TG Therapeutics, Inc. | Healthcare | $0.45B | $8.32B |
| 70 | NVAX | Novavax, Inc. | Healthcare | $0.44B | $2.11B |
| 71 | QGEN | Qiagen N.V. | Healthcare | $0.42B | $9.38B |
| 72 | HSIC | Henry Schein, Inc. | Healthcare | $0.42B | $9.48B |
| 73 | ALGN | Align Technology, Inc. | Healthcare | $0.41B | $10.20B |
| 74 | ATR | AptarGroup, Inc. | Healthcare | $0.39B | $7.58B |
| 75 | ACAD | Acadia Pharmaceuticals Inc. | Healthcare | $0.39B | $3.21B |
| 76 | COO | The Cooper Companies, Inc. | Healthcare | $0.37B | $10.38B |
| 77 | RIGL | Rigel Pharmaceuticals, Inc. | Healthcare | $0.37B | $0.88B |
| 78 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | $0.35B | $10.53B |
| 79 | ENSG | The Ensign Group, Inc. | Healthcare | $0.34B | $10.10B |
| 80 | HALO | Halozyme Therapeutics, Inc. | Healthcare | $0.32B | $12.44B |
| 81 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | $0.31B | $29.95B |
| 82 | KYMR | Kymera Therapeutics, Inc. | Healthcare | $0.31B | $8.87B |
| 83 | AUPH | Aurinia Pharmaceuticals Inc. | Healthcare | $0.29B | $2.18B |
| 84 | ONC | BeOne Medicines AG | Healthcare | $0.29B | $39.49B |
| 85 | INVA | Innoviva, Inc. | Healthcare | $0.27B | $1.50B |
| 86 | BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | $0.26B | $2.06B |
| 87 | PODD | Insulet Corporation | Healthcare | $0.25B | $9.58B |
| 88 | ALKS | Alkermes plc | Healthcare | $0.24B | $6.67B |
| 89 | RVTY | Revvity, Inc. | Healthcare | $0.24B | $17.30B |
| 90 | LNTH | Lantheus Holdings, Inc. | Healthcare | $0.23B | $6.53B |
| 91 | ICLR | ICON Public Limited Company | Healthcare | $0.23B | $12.68B |
| 92 | HQY | HealthEquity, Inc. | Healthcare | $0.22B | $7.46B |
| 93 | CPRX | Catalyst Pharmaceuticals Inc | Healthcare | $0.21B | $3.85B |
| 94 | INDV | Indivior Pharmaceuticals, Inc. | Healthcare | $0.21B | $4.18B |
| 95 | OPCH | Option Care Health, Inc. | Healthcare | $0.21B | $4.66B |
| 96 | KRYS | Krystal Biotech, Inc. | Healthcare | $0.20B | $9.51B |
| 97 | DOCS | Doximity, Inc. | Healthcare | $0.20B | $5.45B |
| 98 | PACS | PACS Group, Inc. | Healthcare | $0.19B | $7.03B |
| 99 | PBH | Prestige Consumer Healthcare Inc. | Healthcare | $0.19B | $2.30B |
| 100 | TMDX | TransMedics Group, Inc. | Healthcare | $0.19B | $2.74B |
No companies match this search.
How this ranking is built
Companies are ranked by net income as reported in their most recent annual filing with the SEC. Figures shown are in US dollars (or percent, as noted), rounded to two decimals.
- Source: annual 10-K / 20-F filings from companies trading on US exchanges (NYSE, Nasdaq, AMEX).
- Fiscal year: whichever annual period the company has most recently filed. Fiscal years don't always align with the calendar year, so the "as of FY" stamp above reflects the most common year across the table.
- Filtered out: warrants, preferred shares, and duplicate listings that share a parent company's financials.
- Size floor: A company qualifies at $500 million in market cap or above. Below that, one mis-stated figure outranks the companies the list is about.
- Currency check: A company whose annual revenue runs above 15 times its market cap is left out, because at that gap the two figures are not in the same currency.
- Currency check: A company whose balance sheet runs above 150 times its market cap is left out for the same reason.
- Update cadence: refreshed as companies file new annual reports (typically within 60–90 days of fiscal year end).
Not financial advice. This is a research tool, not a recommendation.